Global Dialysis Devices Market to Progress at a Substantial CAGR of 4.84% Reaching USD 94.30 billion by 2026, Asserts DelveInsight

The demand for Dialysis Devices is witnessing a surge majorly due to the rising prevalence of kidney failure due to various reasons such as the rising geriatric population wherein age acts as a major risk factor for loss of kidney function leading to a surge in the Dialysis Devices market. Furthermore, the rising prevalence of diabetes and hypertension are the key factors which are extensively linked with kidney failure acting as a major influential factor in boosting the growth of the Dialysis Devices market.

LAS VEGAS, April 19, 2022 /PRNewswire/ -- DelveInsight's Dialysis Market Insights and Forecast report provides the current and forecastDialysis Market, upcoming innovations in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Dialysis Market. 

Some of the essential takeaways from the Dialysis Market report: 

• As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth in the Dialysis market.
• Some of the Global Dialysis Device companies with dialysis access devices in various stages of development include Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, Cantel Medical Corporation, NIKKISO CO., LTD, Asahi Kasei Medical, NxStage Medical, Inc. Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd., Dialco Medical Inc., SWS Hemodialysis Care Co., Ltd, TORAY MEDICAL CO, LTD., Trivitron Healthcare,  BLT Biolight Meditech, QUANTA Dialysis Technologies, and others.
• DelveInsight analysis states that the Global Dialysis Market was valued at USD 71.00 Billion in 2020, growing at a CAGR of 4.84% during the forecast period from 2021 to 2026 to reach USD 94.30 Billion by 2026. 
• In March 2021, Baxter Healthcare Corporation received regulatory approval from the US Food and Drug Administration for their AK 98 Dialysis Machine, classified as a Class II medical device.
• In January 2021, the US Food and Drug Administration granted regulatory approval to Quanta Dialysis Technologies Ltd for their product- the hemodialysis system SC+. The device is a portable system that is capable of offering dialysis care comparable to full-sized dialysis equipment in a range of care settings.
• In August 2020, the US FDA granted the emergency-use authorization (EUA) for REGIOCIT which is intended to be used as a replacement solution specifically in adult patients who are being treated with CRRT and for whom regional citrate anticoagulation is considered appropriate.
• In October 2018, Baxter received the CE mark approval for the next-generation continuous renal replacement therapy using the PrisMax system.

To pick on the latest highlights related to the Dialysis implantable device market, get a snapshot of the key highlights entailed in the Dialysis Market Sample Report

Dialysis Devices Overview 

Dialysis Devices are medical equipment and consumables that help in substituting for kidney function in events of kidney failure or compromised kidney function to compensate and remove toxins from the body. The Dialysis access devices is made up of a series of membranes that act as filters and a special liquid called dialysate. The membranes filter waste products from the blood, which are then passed into the dialysate fluid.  This Dialysis Device/machine itself can be thought of as an artificial kidney.

Dialysis Devices Market Insight 

Geographically, the Global Dialysis market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue North America currently hols the Global Dialysis market share and is expected to remain constant during the forecast period. This domination is owing is due to the rising prevalence of kidney disorders, the rising population of patients suffering from lifestyle disorders such as obesity and hypertension leading to a high surge in Dialysis Devices market growth. Moreover, extensive efforts in product developmental activities and the growing popularity of home-based dialysis devices are further expected to drive the Dialysis Devices market in the North American region.

In addition to the above-stated factors, the product development activities, product approvals, and the extensive coverage of procedural costs specifically in the United States and Canada are expected to further boost the Dialysis Devices market in the coming years. For instance, in March 2021, Baxter Healthcare Corporation received regulatory approval from the US Food and Drug Administration for their AK 98 Dialysis Machine, classified as a Class II medical device.

Click here to understand more about the key players in the Dialysis Market and their future @ Dialysis Future Assessment

Dialysis Devices Market Dynamics 

The rise in demand for Dialysis Devices is primarily attributed to the rising prevalence of kidney failure due to various reasons such as the rising geriatric population wherein age acts as a major risk factor for loss of kidney function leading to growth in the Dialysis Devices market. Also, the rising prevalence of diabetes in which hyperglycemia is linked with blood vessel damage in the kidneys, and hypertension are the key factors that are extensively linked with kidney failure directly increasing the Dialysis Devices market. Additionally, technological advancements such as the development of continuous renal replacement therapy (CRRT) have also been a major influential factor in boosting the growth of the Dialysis Devices market in the coming years. 

However, on the contrary, certain factors such as procedure-related complications and the high cost of Dialysis services for patients in growing economies may be growth-restraining factors for the Dialysis Devices market. Moreover, the COVID-19 pandemic had a profound impact on elective and non-urgent surgeries across the countries. The Dialysis Devices market is primarily affected by the outbreak of the COVID-19 pandemic. The government imposed lockdowns to curb the spread of the virus leading to restrictions on movement and a decrease in regular check-ups leading to a decrease in the Dialysis Devices market growth.

To gain a better understanding of the COVID-19 impact on Dialysis, get a snapshot of the COVID-19 Impact on the Dialysis Market

Scope of the Dialysis Market Report

• Coverage: Global
• Study Period: 2021-2026
• Market Segmentation By Product Type - Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines, And Consumables
• Market Segmentation By Mobility - Stationary Dialysis Device, And Portable Dialysis Device
• Market Segmentation By End-User- Hospitals, Dialysis Centers, And Homecare Settings
• Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of the   World
• Key Dialysis Companies -  Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, Cantel Medical Corporation, NIKKISO CO., LTD, Asahi Kasei Medical, NxStage Medical, Inc. Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd., Dialco Medical Inc., SWS Hemodialysis Care Co., Ltd, TORAY MEDICAL CO, LTD., Trivitron Healthcare,  BLT Biolight Meditech, QUANTA Dialysis Technologies
• Porter's Five Forces Analysis
• Product Profiles
• Case Studies 
• KOL's Views
• Analyst's View

Delveinsight Analysis: The Global Dialysis Devices market was valued at USD 71.00 billion in 2020, growing at a CAGR of 4.84% during the forecast period from 2021 to 2026 to reach USD 94.30 billion by 2026.

Know more about which MedTech player is set to emerge as the trendsetter in the Global Dialysis Market @ Key Dialysis Companies Analysis 

Table of Contents 

Learn more about the mini dialysis devices @ Wearable Dialysis Device 

Related Reports

Chronic Kidney Disease Pipeline

Chronic Kidney Disease Pipeline Insight, 2022 report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the key Chronic Kidney Disease companies involved such as Bayer, AstraZeneca, Celgene, Ipsen, among others.

Peritoneal Dialysis Equipment Market

The Global Peritoneal Dialysis Equipment market was valued at USD 4.12 billion in 2020, growing at a CAGR of 5.89 % during the forecast period from 2021 to 2026, to reach USD 5.81 billion by 2026. The report delivers an in-depth understanding of Peritoneal Dialysis Equipment market trends, drivers and barriers, and key Peritoneal Dialysis Equipment companies involved such as Baxter, Fresenius Medical Care AG & Co. KGaA, Terumo Corporation, Medtronic, Utah Medical Products, Polymedicure, Cook, Cardiomed, Angiplast, and others.

Acute Kidney Injury Market

Acute Kidney Injury Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Acute Kidney Injury companies involved such as Alloksys, Vifor Pharma, Exponential Biotherapies, Astellas Pharma, Pharming Technologies, among others.

Anemia in Chronic Kidney Disease Pipeline

Anemia in Chronic Kidney Disease Pipeline Insight, 2022 report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the key Anemia in Chronic Kidney Disease companies involved such as Pieris Pharmaceuticals, Jiangsu HengRui Medicine, Shenyang Sunshine Pharmaceutical, Biocad, among others.

Diabetic Kidney Disease Pipeline

Diabetic Kidney Disease Pipeline Insight, 2022 report provides comprehensive insights about pipeline drug profiles, including clinical and non-clinical stage products. It also covers the key Diabetic Kidney Disease companies involved such as Gilead Sciences, Kyowa Kirin, Bayer, among others.

Polycystic Kidney Disease Pipeline

Polycystic Kidney Disease Pipeline Insight, 2022 report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the key Anemia in Polycystic Kidney Disease companies involved such as Abbott, Reata Pharmaceuticals, XORTX Therapeutics, Sanofi Genzyme, among others.

Kidney Transplant Rejection Pipeline

Kidney Transplant Rejection Pipeline Insight, 2022 report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the key Anemia in Kidney Transplant Rejection companies involved such as Medeor Therapeutics, Talaris Therapeutics, CSL Behring, Novartis, among others.

Interested to know more about the breakthrough happenings? Take a look at the posts below 

• MedTech Industry Roars Back as FDA Approvals Soar
• Acute Kidney Injury Market Outlook
• Medical Devices Market Blooms as the Key MedTech Companies Continue to Bring-In Innovation
• Acute Kidney Injury Treatment Market
• IgA Nephropathy Market
• Wearable Devices: Weighing the Potential Benefits and Pitfalls of the Innovative Wearable Products

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Connect With Us at LinkedIn | Facebook | Twitter

Contact Us
Shruti Thakur 
[email protected] 
+1(919)321-6187 
www.delveinsight.com

SOURCE DelveInsight Business Research, LLP